Congress Passes Breast/Cervical Cancer Bill

Publication
Article
OncologyONCOLOGY Vol 14 No 12
Volume 14
Issue 12

Congress finally passed a bill (H.R. 4386/S. 662) that allows states to provide medical treatment for women with breast and cervical cancer. At their option (there is no requirement), states can treat women who have tested positive in a screening

Congress finally passed a bill (H.R. 4386/S. 662) that allows states to providemedical treatment for women with breast and cervical cancer. At their option(there is no requirement), states can treat women who have tested positive in ascreening program run by the Centers for Disease Control and Prevention (CDC).Frequently, these screening programs are located at community health clinics inpoor urban areas and on Native American reservations, clinics funded by theHealth Resources and Services Administration (HRSA). Nearly 2 million women havebeen screened since 1990. The budget in fiscal year 2000 for this NationalBreast and Cervical Cancer Early Detection Program was $167 million. In thepast, many of the women diagnosed with cancer had nowhere to turn for medicaltreatment because they were uninsured. The Breast and Cervical Cancer TreatmentAct opens up a treatment avenue for some of them. States will be able to providetreatment through Medicaid, and will get an enhanced federal matching grant forestablishing that treatment program.

Recent Videos
Updated results from the 1b/2 ELEVATE study elucidate synergizing effects observed with elacestrant plus targeted therapies in ER+/HER2– breast cancer.
Patients with ESR1+, ER+/HER2– breast cancer resistant to chemotherapy may benefit from combination therapy with elacestrant.
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
A prospective trial may help affirm ctDNA as a non-invasive option of predicting responses to radiotherapy among those with gynecologic cancers.
ctDNA reductions or clearance also appeared to correlate with a decrease in disease burden during the pre-boost phase of radiotherapy.
Investigators evaluated ctDNA as a potentially noninvasive method to predict response to radiotherapy among those with gynecologic malignancies.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Related Content